Common 0 6 0 6 B-chronic_disease
variable 7 15 7 15 I-chronic_disease
immunodeficiency 16 32 16 32 I-chronic_disease

Cutaneous 0 9 33 42 B-cancer
subcutaneous 10 22 43 55 I-cancer
soft 23 27 56 60 I-cancer
tissue 28 34 61 67 I-cancer
, 34 35 67 68 O
or 36 38 69 71 O
superficial 39 50 72 83 O
lymphatic 51 60 84 93 B-cancer
metastasis 61 71 94 104 I-cancer
not 72 75 105 108 O
suitable 76 84 109 117 O
for 85 88 118 121 O
surgical 89 97 122 130 O
resection 98 107 131 140 O

Eastern 0 7 141 148 B-clinical_variable
Cooperative 8 19 149 160 I-clinical_variable
Oncology 20 28 161 169 I-clinical_variable
Group 29 34 170 175 I-clinical_variable
( 35 36 176 177 I-clinical_variable
ECOG 36 40 177 181 I-clinical_variable
) 40 41 181 182 I-clinical_variable
performance 42 53 183 194 I-clinical_variable
status 54 60 195 201 I-clinical_variable
0 61 62 202 203 B-lower_bound
to 63 65 204 206 O
2 66 67 207 208 B-upper_bound

Histopathologically 0 19 209 228 O
confirmed 20 29 229 238 O
melanoma 30 38 239 247 B-cancer
, 38 39 247 248 O
Merkel 40 46 249 255 B-cancer
cell 47 51 256 260 I-cancer
carcinoma 52 61 261 270 I-cancer
or 62 64 271 273 O
other 65 70 274 279 O
solid 71 76 280 285 B-cancer
tumor 77 82 286 291 I-cancer
malignancy 83 93 292 302 I-cancer

History 0 7 303 310 O
of 8 10 311 313 O
high 11 15 314 318 O
grade 16 21 319 324 O
( 22 23 325 326 O
CTCAE 23 28 326 331 B-clinical_variable
â‰¥ 29 30 332 333 O
Grade 31 36 334 339 B-lower_bound
3 37 38 340 341 I-lower_bound
) 38 39 341 342 O
immune 40 46 343 349 O
mediated 47 55 350 358 O
adverse 56 63 359 366 O
event 64 69 367 372 O
from 70 74 373 377 O
prior 75 80 378 383 B-treatment
cancer 81 87 384 390 I-treatment
immunotherapy 88 101 391 404 I-treatment

History 0 7 405 412 O
of 8 10 413 415 O
symptomatic 11 22 416 427 B-chronic_disease
autoimmune 23 33 428 438 I-chronic_disease
disease 34 41 439 446 I-chronic_disease
( 42 43 447 448 O
such 43 47 448 452 O
as 48 50 453 455 O
lupus 51 56 456 461 B-chronic_disease
, 56 57 461 462 O
scleroderma 58 69 463 474 B-chronic_disease
, 69 70 474 475 O
Crohn 71 76 476 481 B-chronic_disease
's 76 78 481 483 I-chronic_disease
disease 79 86 484 491 I-chronic_disease
, 86 87 491 492 O
ulcerative 88 98 493 503 B-chronic_disease
colitis 99 106 504 511 I-chronic_disease
) 106 107 511 512 O
requiring 108 117 513 522 O
systemic 118 126 523 531 B-treatment
treatment 127 136 532 541 I-treatment
( 137 138 542 543 O
for 138 141 543 546 O
example 142 149 547 554 O
corticosteroids 150 165 555 570 B-treatment
or 166 168 571 573 O
immunosuppressants 169 187 574 592 B-treatment
) 187 188 592 593 O

Intermittent 0 12 594 606 O
or 13 15 607 609 O
chronic 16 23 610 617 O
use 24 27 618 621 O
of 28 30 622 624 O
oral 31 35 625 629 O
or 36 38 630 632 O
intravenous 39 50 633 644 O
antiherpetic 51 63 645 657 B-treatment
drug 64 68 658 662 I-treatment
( 69 70 663 664 O
such 70 74 664 668 O
as 75 77 669 671 O
acyclovir 78 87 672 681 B-treatment
) 87 88 681 682 O

Known 0 5 683 688 O
human 6 11 689 694 B-chronic_disease
immunodeficiency 12 28 695 711 I-chronic_disease
virus 29 34 712 717 I-chronic_disease
( 35 36 718 719 I-chronic_disease
HIV 36 39 719 722 I-chronic_disease
) 39 40 722 723 I-chronic_disease
infection 41 50 724 733 I-chronic_disease

Known 0 5 734 739 O
severe 6 12 740 746 B-chronic_disease
congenital 13 23 747 757 I-chronic_disease
or 24 26 758 760 O
acquired 27 35 761 769 O
cellular 36 44 770 778 O
or 45 47 779 781 O
humoral 48 55 782 789 B-chronic_disease
immunodeficient 56 71 790 805 I-chronic_disease
or 72 74 806 808 O
immunocompromised 75 92 809 826 B-chronic_disease
patients 93 101 827 835 I-chronic_disease

Life 0 4 836 840 B-clinical_variable
expectancy 5 15 841 851 I-clinical_variable
> 16 17 852 853 O
4 18 19 854 855 B-lower_bound
months 20 26 856 862 I-lower_bound

Patients 0 8 863 871 O
requiring 9 18 872 881 O
chronic 19 26 882 889 B-treatment
high 27 31 890 894 I-treatment
dose 32 36 895 899 I-treatment
immunosuppressants 37 55 900 918 I-treatment
including 56 65 919 928 O
steroids 66 74 929 937 B-treatment

Previously 0 10 938 948 O
infected 11 19 949 957 O
, 19 20 957 958 O
with 21 25 959 963 O
evidence 26 34 964 972 O
of 35 37 973 975 O
immunity 38 46 976 984 O
and 47 50 985 988 O
no 51 53 989 991 O
evidence 54 62 992 1000 O
of 63 65 1001 1003 O
active 66 72 1004 1010 B-chronic_disease
hepatitis 73 82 1011 1020 I-chronic_disease

Receipt 0 7 1021 1028 O
of 8 10 1029 1031 O
a 11 12 1032 1033 O
therapeutic 13 24 1034 1045 O
anticoagulant 25 38 1046 1059 B-treatment

Receipt 0 7 1060 1067 O
of 8 10 1068 1070 O
another 11 18 1071 1078 O
cancer 19 25 1079 1085 B-treatment
therapy 26 33 1086 1093 I-treatment
( 34 35 1094 1095 O
targeted 35 43 1095 1103 B-treatment
therapy 44 51 1104 1111 I-treatment
, 51 52 1111 1112 O
chemotherapy 53 65 1113 1125 B-treatment
, 65 66 1125 1126 O
investigational 67 82 1127 1142 B-treatment
therapy 83 90 1143 1150 I-treatment
, 90 91 1150 1151 O
immunotherapy 92 105 1152 1165 B-treatment
, 105 106 1165 1166 O
radiotherapy 107 119 1167 1179 B-treatment
or 120 122 1180 1182 O
surgery 123 130 1183 1190 B-treatment
) 130 131 1190 1191 O
which 132 137 1192 1197 O
is 138 140 1198 1200 O
yielding 141 149 1201 1209 O
an 150 152 1210 1212 O
overall 153 160 1213 1220 O
response 161 169 1221 1229 O
( 170 171 1230 1231 O
by 171 173 1231 1233 O
response 174 182 1234 1242 O
criteria 183 191 1243 1251 O
in 192 194 1252 1254 O
this 195 199 1255 1259 O
study 200 205 1260 1265 O
) 205 206 1265 1266 O

Receipt 0 7 1267 1274 O
of 8 10 1275 1277 O
live 11 15 1278 1282 B-treatment
vaccine 16 23 1283 1290 I-treatment
within 24 30 1291 1297 O
28 31 33 1298 1300 B-upper_bound
days 34 38 1301 1305 I-upper_bound
of 39 41 1306 1308 O
planned 42 49 1309 1316 O
first 50 55 1317 1322 O
dose 56 60 1323 1327 O
of 61 63 1328 1330 O
TVEC 64 68 1331 1335 B-treatment

Woman 0 5 1336 1341 B-gender
of 6 8 1342 1344 O
childbearing 9 21 1345 1357 O
potential 22 31 1358 1367 O
that 32 36 1368 1372 O
is 37 39 1373 1375 O
pregnant 40 48 1376 1384 B-pregnancy

Woman 0 5 1385 1390 B-gender
of 6 8 1391 1393 O
childbearing 9 21 1394 1406 O
potential 22 31 1407 1416 O
unwilling 32 41 1417 1426 B-contraception_consent
to 42 44 1427 1429 I-contraception_consent
use 45 48 1430 1433 I-contraception_consent
effective 49 58 1434 1443 I-contraception_consent
contraception 59 72 1444 1457 I-contraception_consent
during 73 79 1458 1464 O
protocol 80 88 1465 1473 O
treatment 89 98 1474 1483 B-treatment
and 99 102 1484 1487 O
for 103 106 1488 1491 O
3 107 108 1492 1493 B-upper_bound
months 109 115 1494 1500 I-upper_bound
after 116 121 1501 1506 O
last 122 126 1507 1511 O
dose 127 131 1512 1516 O
of 132 134 1517 1519 O
Talimogene 135 145 1520 1530 B-treatment
Laherparepvec 146 159 1531 1544 I-treatment

breast 0 6 1545 1551 O
- 6 7 1551 1552 O
feed 7 11 1552 1556 O
during 12 18 1557 1563 O
protocol 19 27 1564 1572 O
treatment 28 37 1573 1582 B-treatment
and 38 41 1583 1586 O
for 42 45 1587 1590 O
3 46 47 1591 1592 B-upper_bound
months 48 54 1593 1599 I-upper_bound
after 55 60 1600 1605 O
last 61 65 1606 1610 O
dose 66 70 1611 1615 O
of 71 73 1616 1618 O
Talimogene 74 84 1619 1629 B-treatment
Laherparepvec 85 98 1630 1643 I-treatment

planning 0 8 1644 1652 B-pregnancy
to 9 11 1653 1655 I-pregnancy
become 12 18 1656 1662 I-pregnancy
pregnant 19 27 1663 1671 I-pregnancy

platelet 0 8 1672 1680 B-clinical_variable
count 9 14 1681 1686 I-clinical_variable
> 15 16 1687 1688 O
50 16 18 1688 1690 B-lower_bound
k 19 20 1691 1692 I-lower_bound
/ 20 21 1692 1693 I-lower_bound
mcL 21 24 1693 1696 I-lower_bound
, 24 25 1696 1697 O
international 26 39 1698 1711 B-clinical_variable
normalized 40 50 1712 1722 I-clinical_variable
ratio 51 56 1723 1728 I-clinical_variable
of 57 59 1729 1731 O
< 60 61 1732 1733 O
1.5 62 65 1734 1737 B-upper_bound

replacement 0 11 1738 1749 B-treatment
therapy 12 19 1750 1757 I-treatment
( 20 21 1758 1759 O
for 21 24 1759 1762 O
example 25 32 1763 1770 O
, 32 33 1770 1771 O
thyroxine 34 43 1772 1781 B-treatment
, 43 44 1781 1782 O
insulin 45 52 1783 1790 B-treatment
) 52 53 1790 1791 O
is 54 56 1792 1794 O
not 57 60 1795 1798 O
considered 61 71 1799 1809 O
a 72 73 1810 1811 O
systemic 74 82 1812 1820 B-treatment
treatment 83 92 1821 1830 I-treatment

woman 0 5 1831 1836 B-gender

